Methadone Clinics in cities of Indiana
Medication Treatment for Opioid Use Disorder Across Indiana
Opioid use disorder treatment in Indiana runs on two tracks that work together.
Methadone is available only through federally certified opioid treatment programs, which the state has concentrated in its larger metro areas like Indianapolis, Fort Wayne, Evansville and South Bend. Buprenorphine, including Suboxone, and naltrexone reach much further, because any clinician with a standard DEA registration can prescribe them in an office and send the prescription to a pharmacy.
For the rural counties where the nearest program is a long drive, telehealth has become the practical bridge to starting and staying on buprenorphine.
The clinic listings on this page show what is available near you. If you need help deciding where to start, the helpline can help you talk you through it.
The Three Medications and the Two Places You Can Get Them
Indiana offers all three FDA-approved medications for opioid use disorder (MOUD), and understanding them is the clearest way to read the listings on this page.
Methadone is a full opioid agonist that prevents withdrawal and cravings. For opioid use disorder, it is dispensed only through a licensed opioid treatment program (OTP), not a regular pharmacy, with dosing that starts daily and can move to take-home doses as treatment stabilizes.
Buprenorphine, the active medicine in Suboxone (buprenorphine-naloxone) and in the monthly Sublocade injection, is a partial agonist with a built-in ceiling that lowers overdose risk. It can be prescribed in a doctor’s office, a health center or an OTP, and filled at a pharmacy.
Naltrexone, including the monthly Vivitrol injection, is not an opioid at all; it blocks opioid effects. It is important to keep in mind that this type of treatment starts only after a person has been off opioids for a set period.
Those medications are delivered in two kinds of settings: opioid treatment programs, which provide methadone and often buprenorphine along with counseling, and office-based opioid treatment (OBOT) through physicians, nurse practitioners and physician assistants who prescribe buprenorphine or naltrexone.
If you want to see how methadone and Suboxone compare in everyday terms, or read more about how methadone treatment works, those guides go deeper than a listing can. The right choice is one you make with a clinician, not one any directory should make for you.
State Rules, Medicaid Coverage and What Treatment Costs in Indiana
Cost is usually the first worry, so start here.
Indiana Medicaid, delivered mainly through the Healthy Indiana Plan (HIP) and the state’s managed care plans under the Family and Social Services Administration (FSSA), covers all three medications for opioid use disorder and Indiana removed prior authorization for these medications to cut delays at the pharmacy counter.
Medicare Part B covers OTP services, and most commercial plans cover buprenorphine and naltrexone. For people who are uninsured or underinsured, Indiana’s Division of Mental Health and Addiction (DMHA) funds treatment for residents with financial need. As well, many programs use sliding-scale fees, so be sure to ask about both when you call.
Federal changes from 2023 and 2024 reshaped what is possible. Since 2023, any provider with a standard DEA registration can prescribe buprenorphine for opioid use disorder, which widened where people can get it. Additionally, federal rules that were updated in 2024 expanded take-home methadone (up to a 28-day supply for stable patients, decided by the program based on stability) and allowed treatment to be initiated through telehealth. Methadone for opioid use disorder remains dispensed only through an OTP
As of June 2026, buprenorphine can still be started through telehealth, including by phone in many cases and without a prior in-person visit. These expanded telehealth rules run through the end of 2026 and are still being finalized, so confirm your current options with a provider. Indiana’s Aaron’s Law backs this up on the safety side, with a statewide standing order that lets any pharmacy dispense naloxone without an individual prescription.
If keeping a steady dose while life changes is your concern, check out why consistent methadone dosing matters.
People who worry about privacy at work can review what an employer can and cannot ask about treatment.
The Opioid Picture in Indiana, and Why it Points Toward Treatment
The trend in Indiana has turned in a hopeful direction. Statewide, the overdose death rate fell from 2023 to 2024 in both urban and rural counties, with the urban rate dropping from 34.1 to 25.1 per 100,000 and the rural rate falling to 20.7. Fentanyl remains the substance most often involved in these deaths, and newer additives in the illicit supply keep the risk unpredictable.
Numbers like these represent real losses in Indiana communities, but they are not the whole story. The same years that saw deaths fall also saw the state widen access to medication and naloxone.
Effective treatment exists in Indiana and it is closer and easier to start than it was a few years ago. The listings on this page are a good place to begin. You can also read more about how opioid use disorder affects the body and brain if that helps you make sense of what you or someone you love is facing.
How to Find a Program and Take the First Step
Starting treatment in Indiana usually begins with an assessment, where a provider reviews your history, talks through which medication fits and explains what dosing will look like. Bring an ID and insurance information if you have them, but a lack of either should not stop you from calling, because many programs can help you sort out coverage.
If you have been using fentanyl, the timing of a first buprenorphine dose matters. This is because starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician will plan that first dose with you.
Some programs offer same-day or next-day intake, so be sure to ask when you call. The clinic listings above are organized so you can find options near you, and as city pages are added, you will be able to drill down to your area.
For the bigger picture of what opioid use disorder treatment involves, or to understand when a higher level of care like inpatient treatment might be discussed, these guides can prepare you for the conversation. To talk to a person now, use a listing’s contact information or the helpline on this page.
Pregnancy, the Justice System and Reentry
Some situations carry added stakes, and Indiana has built specific supports for them.
For pregnant Hoosiers, methadone and buprenorphine are the recommended standard of care. The Indiana Pregnancy Promise Program, run through FSSA and the Medicaid managed care plans under a federal Maternal Opioid Misuse model, assigns a case manager who coordinates prenatal care, OUD treatment and support for a full year after pregnancy. Treatment is the protective step here, and the program is designed to keep parents and babies healthy and together. One way this is ensured is through care teams that plan for neonatal opioid withdrawal syndrome (NOWS) when it applies.
For people involved with the justice system, Indiana’s Recovery Works program funds treatment and reentry services for justice-involved residents without coverage, and the state’s Regional Recovery Hubs connect people leaving incarceration with peer support and medication continuity.
If you are helping a loved one navigate any of this, our guide for families supporting someone in treatment and our overview of methadone and pregnancy cover the questions that come up most.
Naloxone and Staying Safer
Naloxone, the medication that reverses an opioid overdose, is widely available in Indiana. Under Aaron’s Law and the state health commissioner’s standing order, any pharmacy can dispense it without an individual prescription. Organizations like Overdose Lifeline and the Indiana Recovery Alliance distribute free kits, including by mail.
Indiana’s Good Samaritan provisions offer limited protection from certain drug-possession charges for someone who calls 911 during an overdose, with conditions, so calling for help is always the right move.
Keeping naloxone on hand matters for anyone using opioids and for the people around them. A return to use can happen in recovery; it is a common, manageable part of treating a chronic condition, not a failure, and having naloxone nearby keeps a setback from becoming a tragedy. You can learn more about recognizing and responding to a methadone overdose and overdose risk in general.
Common Questions About Treatment in Indiana
Is methadone or Suboxone better?
Neither is better for everyone. Methadone is a full agonist taken daily at first through a clinic and can suit people who need more structure or who have not done well on buprenorphine. Buprenorphine (Suboxone) has a lower overdose risk and the convenience of pharmacy pickup. The right fit depends on your history, your schedule and your goals, which is a decision to make with your clinician.
Do I have to go to a clinic every day for methadone?
At first, usually yes. Federal rules updated in 2024 let stable patients earn take-home doses, up to a 28-day supply, with eligibility decided by the program based on how treatment is going. Buprenorphine and naltrexone do not require daily clinic visits.
Can I start treatment by telehealth in Indiana?
Buprenorphine can be started by telehealth, including by phone in many cases and without an in-person visit first. Methadone for opioid use disorder is started and dispensed through an opioid treatment program, though some programs can begin care with a telehealth visit.
Will Medicaid pay for my treatment?
Indiana Medicaid, including the Healthy Indiana Plan, covers methadone, buprenorphine and naltrexone, with the state removing prior authorization for these FDA-approved OUD medications. If you are uninsured, DMHA-funded programs and sliding-scale fees can help. Be sure to ask each program what it offers and to help you to understand your coverage.
What if there is no opioid treatment program near me?
Many Indiana counties do not have a local methadone clinic. In those areas, office-based buprenorphine through a local clinician or telehealth is often the most reachable option, and a nearby city’s program may accept new or transferring patients. The listings can help you find the closest options.
Last reviewed June 2026.
Sources:
- Indiana Department of Health, 2024 Indiana Overdose and Suicide Report (released 2025).
- Indiana Family and Social Services Administration, Division of Mental Health and Addiction, About DMHA and Regional Recovery Hubs.
- Indiana Pregnancy Promise Program, For Pregnant Individuals, FSSA.
- Indiana Code 16-42-27-2 (Aaron’s Law statewide naloxone standing order); Overdose Lifeline, Aaron’s Law.
- SAMHSA and DEA, telemedicine flexibilities for buprenorphine, extended through December 31, 2026; SAMHSA 42 CFR Part 8 final rule (2024). DEA.gov
- U.S. FDA and SAMHSA, MOUD overview (the three approved medications and their settings). www.samhsa.gov/
Methadone Centers is a treatment-discovery and education resource, not a medical provider, and does not provide medical advice, diagnosis, or treatment. Always consult a qualified clinician about your care.
Some calls placed through this site may be answered by a sponsored helpline. There is no obligation to enter treatment, and you can also contact providers directly using the listing information on this page.